SCHEMBL1099400

SCHEMBL1099400

O=C1NCCN1CCN(c1sc2ccccc2c1Cl)S(=O)(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.40
KDR P35968 1/20 0.40
ALDH1A1 P00352 3/20 0.35
TRPM8 Q7Z2W7 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTR2A P28223 4/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
LMNA P02545 1/20 0.32
PER2 O15055 1/20 0.32
HTR1A P08908 2/20 0.32
DRD2 P14416 2/20 0.32
HTR7 P34969 2/20 0.32
HTR6 P50406 2/20 0.32
ADAMTS5 Q9UNA0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099478 0.88 RET (0.40) RETKDRALDH1A1TRPM8HTR2A
SCHEMBL1098125 0.84 RAB9A (0.48) ALDH1A1TRPM8KMT2ARAB9ARXFP1
SCHEMBL1098547 0.82 LMNA (0.48) ALDH1A1TRPM8HTR2AKMT2AMAPT
SCHEMBL1099757 0.77 LOXL2 (0.43) TRPM8LMNAKDM4E
SCHEMBL1099333 0.76 ALDH1A1 (0.42) ALDH1A1TRPM8TDP1HTR2AMAPT
SCHEMBL1098457 0.76 NR1I2 (0.44) ALDH1A1TRPM8KMT2AADAMTS5
SCHEMBL1099290 0.75 TRPM8 (0.41) ALDH1A1TRPM8TDP1MAPTKDM4E
SCHEMBL1098670 0.75 TDP1 (0.49) TRPM8TDP1KMT2AMAPTCYP2C9
SCHEMBL1097384 0.72 PTGES (0.45) ALDH1A1TRPM8KMT2AMAPTRAB9A
SCHEMBL1099099 0.72 ADAMTS5 (0.42) ALDH1A1TDP1KMT2ARAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 RET 1221/4885KDR 3861/4885ALDH1A1 3091/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 RET 1221/4885KDR 3861/4885ALDH1A1 3091/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 RET 1221/4885KDR 3861/4885ALDH1A1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.